Skip to product information
1 of 1

BT Lab

SKU:E1230Hu

Human amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

Human amyloid beta peptide 1-40,Aβ1-40 ELISA Kit

Regular price $458.00 USD
Regular price Sale price $458.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Standard Range
Sensitivity

Contact us for 48 wells and bulk quote

Introducing the Human Amyloid Beta Peptide 1-40, AΒ1-40 ELISA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of the AΒ1-40 peptide in human samples. This ELISA kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.

The Human Amyloid Beta Peptide 1-40, AΒ1-40 ELISA Kit employs a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) technique, enabling the quantification of AΒ1-40 peptide levels with exceptional precision. This kit includes all the necessary components, meticulously optimized and validated, to streamline the experimental process and minimize potential errors.

With its user-friendly protocol, the Human Amyloid Beta Peptide 1-40, AΒ1-40 ELISA Kit offers a seamless experience for researchers and clinicians alike. The kit's comprehensive instructions provide clear guidance, ensuring ease of use and enabling swift and accurate analysis of AΒ1-40 peptide concentrations in human samples.

The Human Amyloid Beta Peptide 1-40, AΒ1-40 ELISA Kit is an indispensable tool for various research applications, including but not limited to Alzheimer's disease studies, neurodegenerative disorder investigations, and biomarker discovery. Its exceptional sensitivity and specificity make it an invaluable asset in elucidating the role of AΒ1-40 peptide in pathological processes and disease progression.

Invest in the Human Amyloid Beta Peptide 1-40, AΒ1-40 ELISA Kit today and unlock the potential for groundbreaking discoveries in the field of neurobiology. With its unparalleled accuracy and reliability, this kit empowers researchers and clinicians to delve deeper into the intricate mechanisms underlying neurodegenerative disorders, ultimately paving the way for novel therapeutic interventions and improved patient outcomes.

View full details